« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 20, Issue 2
, Pages 219-229
, June 2007
Risk assessment in haematopoietic stem cell transplantation: Impact of donor–recipient sex combination in allogeneic transplantation
References
- . Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. The Journal of Clinical Investigation. 1977;59:625–632
- . Skin. Transplantation Bulletin. 1955;2:148–149
- Alloimmunity to human H-Y. Lancet. 1976;2:1206
- . The influence of donor-recipient sex mismatchingon on the outcome of allogeneic BMT in leukaemias. Bone Marrow Transplantation. 1989;4:8
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet. 1998;352:1087–1092
- Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood. 2004;103:347–352
- The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplantation. 2005;35:609–617
- Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Transplantation. 2006;82:218–226
- Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet. 2003;362:610–615
- Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation. 1991;51:1197–1203
- Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination. Clinical Transplantation. 1998;12:84–92
- Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. The Hematology Journal. 2001;2:363–370
- Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood. 2002;100:3877–3886
- Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time–a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplantation. 1996;17:13–18
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
- Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103:1961–1964
- Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood. 2003;102:388–393
- . Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. The New England Journal of Medicine. 1977;296:61–66
- . Gender-specific issues in liver and kidney failure and transplantation: a review. Journal of Women's Health. 2005;14:617–626
- Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 1995;346:1117–1121
- Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transplantation. 2002;8:514–518
- The effect of donor gender on graft survival. Journal of the American Society of Nephrology. 2002;13:2570–2576
- . The impact of gender on renal transplantation. Transplantation. 1994;58:1145–1152
- Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. The New England Journal of Medicine. 1981;304:1529–1533
- Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555–562
- Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86:2041–2050
- Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756–763
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390–3400
- Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620–1629
- Reduced-intensity conditioning does not improve survival compared to standard conditioning for patients with myeloma. Bone Marrow Transplantation. 2005;35:S48
- CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proceedings of the National Academy of Sciences of the USA. 1999;96:8639–8644
- The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. Journal of Immunology. 2000;164:2807–2814
- Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 1995;269:1588–1590
- The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity. 1997;6:273–281
- DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood. 2000;95:1100–1105
- UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood. 2000;96:3126–3132
- The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood. 2002;99:3027–3032
PII: S1521-6926(06)00067-3
doi: 10.1016/j.beha.2006.09.007
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
Best Practice & Research Clinical Haematology
Volume 20, Issue 2
, Pages 219-229
, June 2007
